Hoare SR - Search Results

1

Allosteric modulators of class B G-protein-coupled receptors.

Hoare SR. Hoare SR. Curr Neuropharmacol. 2007 Sep;5(3):168-79. doi: 10.2174/157015907781695928. Curr Neuropharmacol. 2007. PMID: 19305799 Free PMC article.

2

Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists.

Hoare SR, Sullivan SK, Ling N, Crowe PD, Grigoriadis DE. Hoare SR, et al. Mol Pharmacol. 2003 Mar;63(3):751-65. doi: 10.1124/mol.63.3.751. Mol Pharmacol. 2003. PMID: 12606786

3

Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.

Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE. Hoare SR, et al. Biochemistry. 2004 Apr 6;43(13):3996-4011. doi: 10.1021/bi036110a. Biochemistry. 2004. PMID: 15049707

4

Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands.

Hoare SR, Sullivan SK, Pahuja A, Ling N, Crowe PD, Grigoriadis DE. Hoare SR, et al. Peptides. 2003 Dec;24(12):1881-97. doi: 10.1016/j.peptides.2003.09.002. Peptides. 2003. PMID: 15127940

5

Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.

Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE. Hoare SR, et al. Peptides. 2005 Mar;26(3):457-70. doi: 10.1016/j.peptides.2004.10.019. Peptides. 2005. PMID: 15652653

6

Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated.

Perry SJ, Junger S, Kohout TA, Hoare SR, Struthers RS, Grigoriadis DE, Maki RA. Perry SJ, et al. Among authors: hoare sr. J Biol Chem. 2005 Mar 25;280(12):11560-8. doi: 10.1074/jbc.M412914200. Epub 2005 Jan 14. J Biol Chem. 2005. PMID: 15653688

7

Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.

Hoare SR. Hoare SR. Drug Discov Today. 2005 Mar 15;10(6):417-27. doi: 10.1016/S1359-6446(05)03370-2. Drug Discov Today. 2005. PMID: 15808821 Review.

8

Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists.

Gross RS, Guo Z, Dyck B, Coon T, Huang CQ, Lowe RF, Marinkovic D, Moorjani M, Nelson J, Zamani-Kord S, Grigoriadis DE, Hoare SR, Crowe PD, Bu JH, Haddach M, McCarthy J, Saunders J, Sullivan R, Chen T, Williams JP. Gross RS, et al. Among authors: hoare sr. J Med Chem. 2005 Sep 8;48(18):5780-93. doi: 10.1021/jm049085v. J Med Chem. 2005. PMID: 16134945

9

Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.

Fleck BA, Chen C, Yang W, Huntley R, Markison S, Nickolls SA, Foster AC, Hoare SR. Fleck BA, et al. Among authors: hoare sr. Biochemistry. 2005 Nov 8;44(44):14494-508. doi: 10.1021/bi051316s. Biochemistry. 2005. PMID: 16262250

10

Single amino acid residue determinants of non-peptide antagonist binding to the corticotropin-releasing factor1 (CRF1) receptor.

Hoare SR, Brown BT, Santos MA, Malany S, Betz SF, Grigoriadis DE. Hoare SR, et al. Biochem Pharmacol. 2006 Jul 14;72(2):244-55. doi: 10.1016/j.bcp.2006.04.007. Epub 2006 Apr 25. Biochem Pharmacol. 2006. PMID: 16750175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results